COMMUNIQUÉS West-GlobeNewswire

Tower One September Update
06/09/2018
VANCOUVER, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE: TO) (OTCQB: TOWTF) (Frankfurt: 1P3N) (“Tower One” or the “Company”) announces a comprehensive update on recent company [...]
Soleno Therapeutics Announces Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger Patients
06/09/2018
Amendment Lowers Minimum Age Inclusion Criteria to Four Years, from Eight Years, to Better Reflect Demographics of PWS Population Top-line Data from Phase III Trial Expected in First Half of 2019 REDWOOD CITY, Calif., [...]
Integrated Cannabis Company, Inc. Provides Corporate Update
06/09/2018
THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, [...]
RedHill Biopharma Announces Advancement to Second Stage of Phase IIa Study with YELIVA® for Cholangiocarcinoma
06/09/2018
The first stage of the Phase IIa study with YELIVA ® for advanced cholangiocarcinoma (bile duct cancer), a highly lethal malignancy, achieved its pre-specified efficacy goal, and the study can therefore continue to its [...]
Atara Biotherapeutics and Moffitt Cancer Center Announce Strategic Collaboration to Develop Next-Generation CAR T Immunotherapies
06/09/2018
Focus on multi-targeted CAR T immunotherapies for patients with acute myelogenous leukemia (AML) and B-cell malignancies Collaboration includes novel CAR T targeting and signaling domains designed to optimize T cell [...]
Specialty Renal Products Announces $3 Million Series A Financing
06/09/2018
SOUTH ORANGE, NJ, Sept. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Specialty Renal Products, Inc. (SRP), a private medical device company focused on the development of products for patients with renal disease, [...]
Metacrine Appoints Hubert Chen, M.D. as Chief Medical Officer and Andrew Guggenhime to the Board of Directors
06/09/2018
SAN DIEGO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Metacrine, Inc., a biotechnology company developing therapies to benefit patients with liver and gastrointestinal diseases (GI), today announced the appointment of Hubert C [...]
Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101
06/09/2018
6 of 8 pts (75%) ORR in treatment-naïve EGFR mutation-positive NSCLC patients Well-tolerated with unremarkable safety profile; No DLTs or related SAEs Phase 3 trial in treatment-naïve EGFR mutation-positive NSCLC [...]
Innovate Biopharmaceuticals to Host Clinical and Scientific Update Event on Thursday, September 6, 2018, in New York City.
06/09/2018
RALEIGH, N.C., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory [...]
Orphazyme to Present at BioCentury 25th Annual NewsMakers in the Biotech Industry
06/09/2018
Orphazyme A/S Investor news No. 09/2018 Company Registration No. 32266355 Copenhagen, September 6, 2018 – Orphazyme A/S , a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]
UPDATE: Emblem signs five-year supply agreement with Compass Cannabis Clinic for Starbuds Canada
06/09/2018
Emblem brands and products to be distributed through Compass’ national retail operations, Starbuds Canada TORONTO, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), [...]
Intrommune Therapeutics Completes Pre-IND Meeting With FDA on INT301 for Peanut Allergy
06/09/2018
New York, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, a New York-based biopharmaceutical company developing a patient-friendly immunotherapy platform for the treatment of food allergies, today announced [...]
CMS Rating for Amedisys Home Health Improves for 11th Consecutive Quarter
06/09/2018
BATON ROUGE, La., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), one of the nation’s leading home healthcare, hospice and personal care companies, received an average rating of 4.38 Stars out of a [...]
Cutera Announces Regulatory Clearance of truSculpt® iD in Canada
06/09/2018
BRISBANE, Calif., Sept. 06, 2018 (GLOBE NEWSWIRE) -- CUTERA, INC., (Nasdaq: CUTR ) (“Cutera” or the “Company”) a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide, [...]
Medibio Clinical Study Shows Over 20% Improvement to Current Diagnostic Standard
06/09/2018
Highlights: Global 230 patient (8 sites) study confirms Medibio’s Depression Diagnostic Aide (DX04) With 70% accuracy, 70% sensitivity and 71% specificity results demonstrate utility in long-term monitoring Study [...]
Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets
06/09/2018
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets Discovery Enabled by Discuva Platform and Proprietary Bacterial Libraries [...]
BeyondSpring’s Lead Asset, Plinabulin, Shows Superior Efficacy Compared to Neulasta for Prevention of Thrombocytopenia Induced by Docetaxel in Phase 2 Trial
06/09/2018
Data Provide Further Support for Plinabulin’s Superior Product Profile Clinical Data Will be Presented at 2018 IASLC 19th World Conference on Lung Cancer NEW YORK , Sept. 06, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc [...]
Auxly and Delta 9 Announce Strategic Investment and Supply Agreement
06/09/2018
VANCOUVER, British Columbia, Sept. 06, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX:CBWTF) (" Auxly ") and Delta 9 Cannabis Inc. (TSX.V -NINE) (“ Delta 9 ”) are pleased to announce that the [...]
CDC Awards BioCryst $35 Million RAPIVAB® Contract for Strategic National Stockpile
06/09/2018
RESEARCH TRIANGLE PARK, N.C., Sept. 06, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, [...]

Pages